Kameel D. Farag
Interim Chief Financial OfficerMr. Kameel D. Farag is Interim Chief Financial Officer of Akari Therapeutics, Plc from October 22, 2025. Mr. Farag is Independent Director of BioVie Inc. since July 2025. He served as Chief Financial Officer at Aspen Neuroscience, Inc. since November 2021 and also served as its Treasurer and head of business operations from 2021 to 2025. He served as a Senior Vice President of Finance at Ionis Pharmaceuticals, Inc. since 2020 until 2020. Prior to Ionis, he was with Amgen, where he held positions of increased leadership, including heading finance for international regions including Chief Financial Officer of Amgen's Intercontinental Region from 2013 to 2018 and as its Head of International FP&A and Interim International Chief Financial Officer from 2009 to 2013. He earned his BA in Business & Economics at University of California, Santa Barbara.
Positions
- Company NameAkari Therapeutics, PlcStock CodeAKTXPositionInterim Chief Financial OfficerColleagues
